Dr. Sweeney on the Phase III ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer

Dr. Oh on the ENZAMET Trial in mHSPCПодробнее

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancerПодробнее

Evaluating Significance of ENZAMET Trial in Metastatic Hormone-Sensitive Prostate CancerПодробнее

Dr. Davis Discusses ANZUP Collaboration on the ENZAMET Trial in Prostate CancerПодробнее

ASCO 2019 ENZAMET (ANZUP 1304) Trial results Plenary presentationПодробнее